Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Cannabis use in adolescence, as measured by self report
questionnaire, is associated with an increased risk of developing schizophrenia. In a historical cohort study of 50 087 Swedish conscripts, Zammit and colleagues (p 1199) report that cannabis use in
adolescence is a risk factor for schizophrenia, independent of the
effects of other drugs or social personality traits. Consideration of
these risks is important in light of debates about legalising cannabis
use. In a New Zealand cohort, Arseneault and colleagues (p 1212) found that adolescent cannabis use is a risk factor for schizophrenia, even after adjustment for pre-existing childhood psychoses. Their longitudinal study shows that early cannabis use (by
age 15) is of greater risk than later use (by age 18). Risk was
specific to cannabis, rather than other drugs. The study supports
efforts to discourage cannabis use among psychologically vulnerable
adolescents.

(Credit: SIPA PRESS/REX)